Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Markus Boehm, Matthew Crawford, Jamie E. Moscovitz & Philip A. Carpino. (2018) Diabetes area patent participation analysis – part II: years 2011-2016. Expert Opinion on Therapeutic Patents 28:2, pages 111-122.
Read now
Read now
Huan Yu & Vincent C Woo. (2017) Emerging use of combination therapies for the management of type 2 diabetes – focus on saxagliptin and dapagliflozin. Diabetes, Metabolic Syndrome and Obesity 10, pages 317-332.
Read now
Read now
André J Scheen. (2014) Pharmacokinetic and toxicological considerations for the treatment of diabetes in patients with liver disease. Expert Opinion on Drug Metabolism & Toxicology 10:6, pages 839-857.
Read now
Read now
André J Scheen. (2013) Pharmacokinetic considerations for the treatment of diabetes in patients with chronic kidney disease. Expert Opinion on Drug Metabolism & Toxicology 9:5, pages 529-550.
Read now
Read now
Articles from other publishers (35)
Khaled Hameed Husain, Saud Faisal Sarhan, Haya Khaled Ali Abdulla AlKhalifa, Asal Buhasan, Abu Saleh Md Moin & Alexandra E. Butler. (2023) Dementia in Diabetes: The Role of Hypoglycemia. International Journal of Molecular Sciences 24:12, pages 9846.
Crossref
Crossref
Firzan Nainu, Andri Frediansyah, Sukamto S. Mamada, Andi Dian Permana, Mirnawati Salampe, Deepak Chandran, Talha Bin Emran & Jesus Simal-Gandara. (2023) Natural products targeting inflammation-related metabolic disorders: A comprehensive review. Heliyon 9:6, pages e16919.
Crossref
Crossref
Fu-Shun Yen, Ming-Chih Hou, Jia-Sin Liu, Chih-Cheng Hsu & Chii-Min Hwu. (2023) Severe hypoglycemia in patients with liver cirrhosis and type 2 diabetes. Frontiers in Medicine 9.
Crossref
Crossref
Fu-Shun Yen, Ming-Chih Hou, Chun-Wei Pan, Jia-Sin Liu, Chih-Cheng Hsu & Chii-Min Hwu. (2022) The Risk of Severe Hypoglycemia and Mortality in Patients With Type 2 Diabetes and Discharged With Acute Liver Injury. Diabetes Care.
Crossref
Crossref
Lucia Brodosi, Salvatore Petta, Maria L. Petroni, Giulio Marchesini & Maria C. Morelli. (2021) Management of Diabetes in Candidates for Liver Transplantation and in Transplant Recipients. Transplantation 106:3, pages 462-478.
Crossref
Crossref
Sílvia Alão, João Conceição, Jorge Dores, Lèlita Santos, Francisco Araújo, Estevão Pape, Mónica Reis, Árcia Chipepo, Edite Nascimento, Ana Baptista, Vanessa Pires, Carlos Marques, Adriana De Sousa Lages, João Pelicano-Romano & Paula M. de Jesus. (2021) Hypoglycemic episodes in hospitalized people with diabetes in Portugal: the HIPOS-WARD study. Clinical Diabetes and Endocrinology 7:1.
Crossref
Crossref
Shuang Li, Li Fang, Amanda Lee, Mark Hayter, Lu Zhang, Yaxin Bi, Xiaxin Wu, Lin Liu, Hong Zhang, Yuan Yuan, Weijuan Gong & Yu Zhang. (2021) The association between diabetes‐related distress and fear of hypoglycaemia in patients with type 2 diabetes mellitus: A cross‐sectional descriptive study. Nursing Open 8:4, pages 1668-1677.
Crossref
Crossref
Pascal Kintz, Nadia Arbouche, Estelle Godard & Jean-Sébastien Raul. (2020) Is a “toxic” death possible with gliclazide, an oral hypoglycemic drug, found at therapeutic concentration?. Toxicologie Analytique et Clinique 32:3, pages 228-234.
Crossref
Crossref
Irene Romera, Ignacio Conget, Luis Alberto Vazquez, Raffaella Gentilella, Jeremie Lebrec, Esteban Jódar & Jesús Reviriego. (2020) Once-weekly dulaglutide versus insulin glargine in the early control of fasting serum glucose and HbA1c. Journal of Diabetes and its Complications 34:7, pages 107575.
Crossref
Crossref
Fatima Al Sayah, Roseanne O. Yeung & Jeffrey A. Johnson. (2019) Association of Depressive Symptoms and Diabetes Distress With Severe Hypoglycemia in Adults With Type 2 Diabetes. Canadian Journal of Diabetes 43:5, pages 316-321.
Crossref
Crossref
Sajjad Esmaeili, Sarwar Azizian, Bahareh Shahmoradi, Sajad Moradi, Mohsen Shahlaei & Reza Khodarahmi. (2019) Dipyridamole inhibits α-amylase/α-glucosidase at sub-micromolar concentrations; in-vitro, in-vivo and theoretical studies. Bioorganic Chemistry 88, pages 102972.
Crossref
Crossref
Claudio Gonzalez, Cyntia Monti, Adolfo Pinzon, Homero Monsanto & Flavia Ejzykowicz. (2018) Prevalence of hypoglycemia among a sample of sulfonylurea-treated patients with Type 2 diabetes mellitus in Argentina: The real-life effectiveness and care patterns of diabetes management (RECAP-DM) study. Endocrinología, Diabetes y Nutrición 65:10, pages 592-602.
Crossref
Crossref
Claudio Gonzalez, Cyntia Monti, Adolfo Pinzon, Homero Monsanto & Flavia Ejzykowicz. (2018) Prevalence of hypoglycemia among a sample of sulfonylurea-treated patients with Type 2 diabetes mellitus in Argentina: The real-life effectiveness and care patterns of diabetes management (RECAP-DM) study. Endocrinología, Diabetes y Nutrición (English ed.) 65:10, pages 592-602.
Crossref
Crossref
Matteo Tacelli, Ciro Celsa, Bianca Magro, Aurora Giannetti, Grazia Pennisi, Federica Spatola & Salvatore Petta. (2018) Antidiabetic Drugs in NAFLD: The Accomplishment of Two Goals at Once?. Pharmaceuticals 11:4, pages 121.
Crossref
Crossref
Andre Gustavo Daher Vianna, Claudio Silva Lacerda, Luciana Muniz Pechmann, Michelle Garcia Polesel, Emerson Cestari Marino & Jose Rocha Faria-Neto. (2018) A randomized controlled trial to compare the effects of sulphonylurea gliclazide MR (modified release) and the DPP-4 inhibitor vildagliptin on glycemic variability and control measured by continuous glucose monitoring (CGM) in Brazilian women with type 2 diabetes. Diabetes Research and Clinical Practice 139, pages 357-365.
Crossref
Crossref
João Conceição, Jorge Dores, Francisco Araújo, Pedro A. Laires, Richard D. Carr, Kimberly Brodovicz, Larry Radican & Ana M. Nogueira. (2017)
Severe hypoglycaemia among patients with type 2 diabetes requiring emergency hospital admission:
T
he
H
ypoglycaemia
I
n
P
ortugal
O
bservational
S
tudy–
E
mergency
R
oom (
HIPOS
–
ER
)
. Diabetes, Obesity and Metabolism 20:1, pages 50-59.
Crossref
Crossref
Jeoungyeon Kim, Hack-Ju Kim & Myoungsook Lee. (2017) The suppressive effect of Gelidium amansi-EtOH extracts on the adipogenesis with MAPK signals in adipocytes with or without macrophages. Food Science and Biotechnology 26:6, pages 1715-1723.
Crossref
Crossref
Sanja Klobucar Majanovic, Andrej Janez, Ivaylo Lefterov, Sanja Tasic & Tatjana Cikac. (2017) The Real-Life Effectiveness and Care Patterns of Diabetes Management Study for Balkan Region (Slovenia, Croatia, Serbia, Bulgaria): A Multicenter, Observational, Cross-Sectional Study. Diabetes Therapy 8:4, pages 929-940.
Crossref
Crossref
Johan Jendle, George Grunberger, Thomas Blevins, Francesco Giorgino, Ryan T. Hietpas & Fady T. Botros. (2016) Efficacy and safety of dulaglutide in the treatment of type 2 diabetes: a comprehensive review of the dulaglutide clinical data focusing on the AWARD phase 3 clinical trial program. Diabetes/Metabolism Research and Reviews 32:8, pages 776-790.
Crossref
Crossref
Ariane K. Kawata, Hilary Wilson, Siew Hwa Ong, Karoly Kulich & Karin Coyne. (2016) Development and Psychometric Evaluation of the Hypoglycemia Perspectives Questionnaire in Patients with Type 2 Diabetes Mellitus. The Patient - Patient-Centered Outcomes Research 9:5, pages 395-407.
Crossref
Crossref
CE Leonard, WB Bilker, CM Brensinger, X Han, JH Flory, DA Flockhart, JJ Gagne, S Cardillo & S Hennessy. (2016) Severe hypoglycemia in users of sulfonylurea antidiabetic agents and antihyperlipidemics. Clinical Pharmacology & Therapeutics 99:5, pages 538-547.
Crossref
Crossref
Diego García-Compeán, José Alberto González-González, Fernando Javier Lavalle-González, Emmanuel Irineo González-Moreno, Jesús Zacarías Villarreal-Pérez & Héctor J. Maldonado-Garza. (2015) Current Concepts in Diabetes Mellitus and Chronic Liver Disease: Clinical Outcomes, Hepatitis C Virus Association, and Therapy. Digestive Diseases and Sciences 61:2, pages 371-380.
Crossref
Crossref
Diego García-Compeán, José Alberto González-González, Fernando Javier Lavalle-González, Emmanuel Irineo González-Moreno, Jesús Zacarías Villarreal-Pérez & Héctor Jesús Maldonado-Garza. (2016) Hepatogenous diabetes: Is it a neglected condition in chronic liver disease?. World Journal of Gastroenterology 22:10, pages 2869.
Crossref
Crossref
Diego García-Compeán, José A. González-González, Fernando J. Lavalle-González, Emmanuel I. González-Moreno, Héctor J. Maldonado-Garza & Jesús Z. Villarreal-Pérez. (2015) The treatment of diabetes mellitus of patients with chronic liver disease. Annals of Hepatology 14:6, pages 780-788.
Crossref
Crossref
Alice P. S. Kong & Juliana C. N. Chan. (2015) Hypoglycemia and Comorbidities in Type 2 Diabetes. Current Diabetes Reports 15:10.
Crossref
Crossref
Chloe L. Edridge, Alison J. Dunkley, Danielle H. Bodicoat, Tanith C. Rose, Laura J. Gray, Melanie J. Davies & Kamlesh Khunti. (2015) Prevalence and Incidence of Hypoglycaemia in 532,542 People with Type 2 Diabetes on Oral Therapies and Insulin: A Systematic Review and Meta-Analysis of Population Based Studies. PLOS ONE 10:6, pages e0126427.
Crossref
Crossref
B. Gallwitz, J. Rosenstock, S. Patel, M. von Eynatten, U. Hehnke, L. Mehlburger, K. A. Dugi & H.-J. Woerle. (2015) Regardless of the degree of glycaemic control, linagliptin has lower hypoglycaemia risk than all doses of glimepiride, at all time points, over the course of a 2-year trial. Diabetes, Obesity and Metabolism 17:3, pages 276-284.
Crossref
Crossref
Zhi-Xu He, Zhi-Wei Zhou, Yinxue Yang, Tianxin Yang, Si-Yuan Pan, Jia-Xuan Qiu & Shu-Feng Zhou. (2015) Overview of clinically approved oral antidiabetic agents for the treatment of type 2 diabetes mellitus. Clinical and Experimental Pharmacology and Physiology 42:2, pages 125-138.
Crossref
Crossref
S. Lane Slabaugh, Yihua Xu, Jane N. Stacy, Jean C. Baltz, Yunus A. Meah, Jean Lian, D. Chad Moretz & Jonathan R. Bouchard. (2015) Antidiabetic Treatment Patterns in a Medicare Advantage Population in the United States. Drugs & Aging 32:2, pages 169-178.
Crossref
Crossref
Brian M. Frier. (2014) Hypoglycaemia in diabetes mellitus: epidemiology and clinical implications. Nature Reviews Endocrinology 10:12, pages 711-722.
Crossref
Crossref
Javier Morales & Doron Schneider. (2014) Hypoglycemia. The American Journal of Medicine 127:10, pages S17-S24.
Crossref
Crossref
S. Goring, N. Hawkins, G. Wygant, M. Roudaut, R. Townsend, I. Wood & A. H. Barnett. (2014) Dapagliflozin compared with other oral anti-diabetes treatments when added to metformin monotherapy: a systematic review and network meta-analysis. Diabetes, Obesity and Metabolism 16:5, pages 433-442.
Crossref
Crossref
Berit InksterRenata L. RihaLiesbeth Van LookRachel WilliamsonStela McLachlanBrian M. FrierMark W.J. StrachanJackie F. PriceRebecca M. Reynolds. (2013) Association Between Excessive Daytime Sleepiness and Severe Hypoglycemia in People With Type 2 Diabetes. Diabetes Care 36:12, pages 4157-4159.
Crossref
Crossref
Wen-Chung HuangWei-Tien ChangShu-Ju WuPei-Yin XuNai-Chun TingChian-Jiun Liou. (2013) Phloretin and phlorizin promote lipolysis and inhibit inflammation in mouse 3T3-L1 cells and in macrophage-adipocyte co-cultures. Molecular Nutrition & Food Research 57:10, pages 1803-1813.
Crossref
Crossref
Alan J. Garber, Martin J. Abrahamson, Joshua I. Barzilay, Lawrence Blonde, Zachary T. Bloomgarden, Michael A. Bush, Samuel Dagogo-Jack, Michael B. Davidson, Daniel Einhorn, W. Timothy Garvey, George Grunberger, Yehuda Handelsman, Irl B. Hirsch, Paul S. Jellinger, Janet B. McGill, Jeffrey I. Mechanick, Paul D. Rosenblit, Guillermo E. Umpierrez & Michael H. Davidson. (2013) American Association of Clinical Endocrinologists’ Comprehensive Diabetes Management Algorithm 2013 Consensus Statement. Endocrine Practice 19, pages 1-48.
Crossref
Crossref